Merck & Co., Inc. (JOBS) CEO "Actively Looking" for Biotech Deals
WSJ -- A day after closing Merck’s $41 billion takeover of Schering-Plough, Merck CEO Dick Clark showed that his appetite for deal-making hasn’t been sated. Clark told us today that the newly combined company is “actively looking” for biotechs to buy or partner with.